Thomas Cueni is director general of the International Federation of Pharmaceutical Manufacturers and Associations, which is based in Geneva.
The pace of health research and development has been extraordinary over the past three years.
Government's pandemic preparation plan depends on commitments from drugmakers


A woman receives a COVID-19 vaccine in Kimana, Kenya, in 2021: Weakening intellectual property protections will not increase the availability of drugs in developing countries. © AP
Thomas Cueni is director general of the International Federation of Pharmaceutical Manufacturers and Associations, which is based in Geneva.
The pace of health research and development has been extraordinary over the past three years.